Weekly tirzepatide injection prescribed by licensed U.S. providers if approved to help you reach weight management and long-term wellness.
Reaux Health is not a compounding pharmacy. Tirzepatide is prepared by a state-licensed partner pharmacy in accordance with applicable pharmacy laws and regulations and is dispensed only in Illinois, where we are currently licensed to operate. Compounded medications are not FDA-approved. A multi-dose vial may contain more than one dose; your provider determines your dose. Compounded medication may be prescribed only when a licensed U.S. medical provider determines it is clinically appropriate for the individual patient.
Compounded tirzepatide is a dual GLP-1 and GIP receptor agonist. In plain terms, it works with two of the hormones your body uses to manage hunger, fullness, and blood sugar. A licensed U.S. provider prescribes it to support weight management by working alongside the systems your body already relies on.
After a meal, your body releases incretin hormones that signal you've had enough and help keep blood sugar steady. Tirzepatide activates both the GLP-1 and GIP pathways at once, so those signals are stronger and last longer, which can mean less hunger, smaller portions that feel satisfying, and fewer cravings between meals.
Because it leans on your body's own rhythms instead of overriding them, most people describe eating as feeling more in control, not more restricted. Alongside everyday nutrition and movement, it's built to support gradual, lasting progress rather than a quick fix.
Tirzepatide and semaglutide are both injectable GLP-1 medications, but they work a little differently.
Tirzepatide is a dual agonist that targets two hormone pathways (GLP-1 and GIP). Semaglutide targets a single one (GLP-1).
Both are once-weekly injections, and the right choice depends on your health profile and goals, which your provider reviews with you.
Tirzepatide is a dual GLP-1 and GIP receptor agonist that works with your body's natural systems to help support metabolic health and weight management.
GLP-1 and GIP are incretin hormones your body releases after eating that help trigger insulin, steady your blood sugar, and signal fullness. By activating both receptors at once, tirzepatide extends those natural signals, influencing appetite, digestion, and metabolism in several ways:
Works with hunger signals in the brain to help reduce cravings and support portion control.
Slows how quickly food leaves your stomach, helping you feel fuller for longer between meals.
In studies of tirzepatide, many patients experienced weight loss when combined with a reduced-calorie diet and increased activity.
These medications work with the systems that help regulate blood sugar. Any effects on your metabolic health are individual, and your provider monitors your progress throughout treatment.
We follow strict clinical protocols and partner with licensed U.S. pharmacies to support quality and safety. Below are answers to common questions to help you feel informed and confident.
Personalized, provider-guided care, built around you.
Start your evaluation